ARM Rebounds 13% as BofA Calls Agentic AI a CPU 'Demand Accelerant'

The Upgrade Behind the Bounce

ARM's 13% move maps cleanly onto a single sell-side note. On June 11, Bank of America's Vivek Arya raised his price target to $335 from $245, pushing the stock up as much as 8.7% intraday. His argument: agentic AI is a "powerful demand accelerant" for CPUs because the orchestration and decision-making work that agents do is better suited to general-purpose processors than to accelerators. On the back of that, he lifted his five-year global CPU market forecast to $170 billion from $125 billion, roughly 37% compound growth by decade's end. It dovetails with ARM management's own 2031 framing — about $25 billion in annual revenue, $9 in EPS, and $15 billion of that from the newly released Arm AGI CPU.

The BofA call didn't land in isolation. It capped a broad agentic-AI upgrade wave — Wells Fargo to $410 from $255, Barclays to $360, and Mizuho out at $500 — all leaning on the same thesis that a structural shift toward CPU-heavy AI data centers favors ARM's architecture.

It's a Bounce Off an Ugly Week

Read this as a reversal, not a fresh breakout. ARM closed June 10 at $307.43, down 5.37%, the low point of a slide from a $417.50 intraday high earlier in the month. The down leg was a semiconductor-wide derisking after Broadcom's update failed to clear elevated AI expectations, compounded by SoftBank's failed effort to secure a $6 billion margin loan against its OpenAI stake. As we flagged last week, ARM trades as the most liquid dollar-denominated proxy for SoftBank's leveraged AI book, so it took the full selloff even with nothing wrong at the operating level.

That context matters for sizing the bounce. The same beta that dragged ARM from $417 to $307 is what's snapping it back to $337 now that an analyst hands the tape a reason to re-risk. ARM has been up around 240%-277% on the year and riding Nvidia's Computex AI-chip momentum; a 13% reversal inside that kind of volatility is the asset behaving normally, not a regime change.

The Tape Is Already Ahead of the Street

Here's the part worth sitting with: even after the upgrade, ARM at ~$337 trades *above* BofA's freshly-raised $335 target. The move priced in the bullish note within hours and then kept going — there's no upside left to the very call that triggered it. Step back to the consensus and the gap widens. The Street's mean target sits well below spot, with the aggregate analyst average near $256 — roughly a third under where the stock is changing hands.

Valuation gives it no cushion: around 24x sales and a P/E north of 180. On Hyperliquid specifically, the HIP-3 perp's thin ~$4.9M 24h book means leverage amplifies both directions, so the 13% perp print runs a touch hot versus spot's rebound into the low-$330s. A name this far ahead of its own analysts on a single upgrade is the kind of setup that re-rates fast in either direction.